Larry Robbins (Trades, Portfolio), the founder of Glenview Capital Management, has made notable adjustments to his investment portfolio in the third quarter of 2024. Established in 2000, Glenview Capital is renowned for its rigorous fundamental research and strategic investment in primarily U.S. markets, with some exposure in Western Europe. The firm operates through two main funds: the Glenview Funds and the Glenview Opportunity Funds, focusing on long/short and concentrated opportunistic investments respectively.
Larry Robbins (Trades, Portfolio) expanded his portfolio by adding six new stocks during the quarter. Noteworthy new positions include:
Significant enhancements were made to existing holdings, including:
The third quarter also saw complete exits from several stocks, including:
Reductions were also prominent in Robbins' strategy, particularly:
As of the third quarter of 2024, Larry Robbins (Trades, Portfolio)' portfolio comprised 46 stocks. The top holdings included 14.53% in CVS Health Corp (NYSE:CVS), 8.55% in Tenet Healthcare Corp (NYSE:THC), 8.21% in Global Payments Inc (NYSE:GPN), 7.05% in The Cigna Group (NYSE:CI), and 5.96% in Corteva Inc (NYSE:CTVA). The investments are mainly concentrated in eight industries: Healthcare, Technology, Industrials, Basic Materials, Consumer Cyclical, Consumer Defensive, Financial Services, and Communication Services.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.